Gene · 6414
Papers2,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cancer-associated fibroblasts in early-stage lung adenocarcinoma correlate with tumor aggressiveness. | Sci Rep | 2023 | 37848457 | PubTator, text mining | PubMed |
| A Transcriptomic Severity Classifier IMX-SEV-3b to Predict Mortality in Intensive Care Unit Patients with COVID-19: A Prospective Observational Pilot Study. | J Clin Med | 2023 | 37834841 | PubTator, text mining | PubMed |
| Serum selenium, selenoprotein P, and glutathione peroxidase 3 during early and late pregnancy in association with gestational diabetes mellitus: Prospective Odense Child Cohort. | Am J Clin Nutr | 2023 | 37813341 | PubTator, text mining | PubMed |
| TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content. | Front Immunol | 2023 | 37809073 | PubTator, text mining | PubMed |
| Metal-coding assisted serological multi-omics profiling deciphers the role of selenium in COVID-19 immunity. | Chem Sci | 2023 | 37799995 | PubTator, text mining | PubMed |
| Single-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemia. | Nat Commun | 2023 | 37798266 | PubTator, text mining | PubMed |
| Metabolic health phenotype better predicts subclinical atherosclerosis than body mass index-based obesity phenotype in the non-alcoholic fatty liver disease population. | Front Nutr | 2023 | 37794971 | PubTator, text mining | PubMed |
| Selenium intake and multiple health-related outcomes: an umbrella review of meta-analyses. | Front Nutr | 2023 | 37781125 | PubTator, text mining | PubMed |
| Selenium in Prostate Cancer: Prevention, Progression, and Treatment. | Pharmaceuticals (Basel) | 2023 | 37765058 | PubTator, text mining | PubMed |
| Cerium Oxide Nanoparticles Protect Cortical Astrocytes from Oxygen-Glucose Deprivation through Activation of the Ca2+ Signaling System. | Int J Mol Sci | 2023 | 37762608 | PubTator, text mining | PubMed |
| Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension? | Biomedicines | 2023 | 37760906 | PubTator, text mining | PubMed |
| Role of Oxidative Stress in Mitochondrial Function: Relevance for Liver Function. | Antioxidants (Basel) | 2023 | 37760087 | PubTator, text mining | PubMed |
| Intertumoral lineage diversity and immunosuppressive transcriptional programs in well-differentiated gastroenteropancreatic neuroendocrine tumors. | Sci Adv | 2023 | 37756410 | PubTator, text mining | PubMed |
| The Role of Organokines in Obesity and Type 2 Diabetes and Their Functions as Molecular Transducers of Nutrition and Exercise. | Metabolites | 2023 | 37755259 | PubTator, text mining | PubMed |
| Matched analysis of circulating selenium with the breast cancer selenotranscriptome: a multicentre prospective study. | J Transl Med | 2023 | 37741974 | PubTator, text mining | PubMed |
| The benefits of rehabilitation exercise in improving chronic traumatic encephalopathy: recent advances and future perspectives. | Mol Med | 2023 | 37740180 | PubTator, text mining | PubMed |
| FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson's disease via m6A-dependent regulation of ATM mRNA. | J Transl Med | 2023 | 37737187 | PubTator, text mining | PubMed |
| Systematic review of type 1 diabetes biomarkers reveals regulation in circulating proteins related to complement, lipid metabolism, and immune response. | Clin Proteomics | 2023 | 37735622 | PubTator, text mining | PubMed |
| Possible role of selenium in ameliorating lead-induced neurotoxicity in the cerebrum of adult male rats: an experimental study. | Sci Rep | 2023 | 37735606 | PubTator, text mining | PubMed |
| Highlighting the idea of exerkines in the management of cancer patients with cachexia: novel insights and a critical review. | BMC Cancer | 2023 | 37730552 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6414/papers?page=14